Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma

by Auro Viswabandya, Sandip Shah, Asis Mukhopadhyay, Rajnish Vasant Nagarkar, Sonica Sachdeva Batra, Luis Lopez-Lazaro, Suresh Kankanwadi, Alok Srivastava
Published 2019-12-01